Erratum: The antioxidant N-acetylcysteine prevents the mitochondrial fragmentation induced by soluble amyloid-? peptide oligomers (Neurodegenerative Diseases (2012) 10 (34-37) DOI: 10.1159/000334901);The antioxidant N-acetylcysteine prevents the mitochondrial fragmentation induced by soluble amyloid-β peptide oligomers

Neurodegenerative Diseases

Volumn 10, Issue 1-4, 2012, Pages 34-37

  Sanmartin, C D ^a   Adasme, T ^a   Hidalgo, C ^a   Paula Lima, A C ^a,b  

^a Faculty of Medicine   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

Author keywords

Mitochondria; Reactive oxygen species; Ryanodine receptors

Indexed keywords

ACETYLCYSTEINE; AMYLOID BETA PROTEIN; ANTIOXIDANT; CALCIUM; CHLOROCRESOL; RYANODINE RECEPTOR;

ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM TRANSPORT; CONFOCAL MICROSCOPY; INCUBATION TIME; MITOCHONDRIAL FRAGMENTATION; MITOCHONDRIAL PERMEABILITY; NERVE CELL; PRIORITY JOURNAL; TIME SERIES ANALYSIS;

EID: 84860224686     PISSN: 16602854     EISSN: 16602862     Source Type: Journal    
DOI: 10.1159/000371787     Document Type: Erratum

References (15)

1. Ferreira ST, Klein WL: The A3β 42 oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol Learn Mem, 2011;96:529-543.
2. De Felice FG, Velasco PT, Lambert MP, Viola K, Fernandez SJ, Ferreira ST, Klein WL: A3β 42 oligomers induce neuronal oxidative stress through an N-methyl- D -aspartate receptor- dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem 2007; 282: 11590-11601.
3. 2+release inducing mitochondrial fragmentation in hippocampal neurons and prevent RyR-mediated dendritic spine remodeling produced by BDNF. Antioxid Redox Signal 2011; 14: 1209-1223.
4. Berridge MJ: Calcium signalling and Alzheimer's disease. Neurochem Res 2011; 36: 1149-1156.
5. Lu YF, Hawkins RD: Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus. J Neurophysiol 2002; 88: 1270-1278.
6. Galeotti N, Quattrone A, Vivoli E, Norcini M, Bartolini A, Ghelardini C: Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. Learn Mem 2008; 15: 315-323.
7. Adasme T, Haeger P, Paula-Lima AC, Espinoza I, Casas-Alarcon MM, Carrasco MA, Hidalgo C: Involvement of ryanodine receptors in neurotrophin-induced hippocampal synaptic plasticity and spatial memory formation. Proc Natl Acad Sci USA 2011; 108: 3029-3034.
8. Hidalgo C, Donoso P: Crosstalk between calcium and redox signaling: from molecular mechanisms to health implications. Antioxid Redox Signal 2008; 10: 1275-1312.
9. Kelliher M, Fastbom J, Cowburn RF, Bonkale W, Ohm TG, Ravid R, Sorrentino V, O'Neill C: Alterations in the ryanodine receptor calcium release channel correlate with Alzheimer's disease neurofibrillary and betaamyloid pathologies. Neuroscience 1999; 92: 499-513.
10. 2+oscillations as a consequence of altered ryanodine receptor function in AD neurons. Channels (Austin) 2011; 5: 9-13.
11. Supnet C, Bezprozvanny I: The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium 2010; 47: 183-189.
12. Mattson MP: A reaction to mitochondria in action. Cell Res 2011; 21: 1279-1282.
13. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X: Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 2009; 29: 9090-9103.
14. Csordas G, Varnai P, Golenar T, Roy S, Purkins G, Schneider TG, Balla T, Hajnoczky G: Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. Mol Cell 2010; 39: 121-132.
15. Alonso MT, Villalobos C, Chamero P, Alvarez J, Garcia-Sancho J: Calcium microdomains in mitochondria and nucleus. Cell Calcium 2006; 40: 513-525.